Intervention

Medical Chart Review

ClinicalTrials.gov intervention label

Clinical trials19
Recruiting6
Common conditions25
Lead sponsors shown14

Clinical trials

19 shown
High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast CancerNCT06492759 · 2025-10-22
RECRUITING
Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY TrialNCT06042569 · 2024-09-16
RECRUITING
Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast CancerNCT05677802 · 2022-12-14
RECRUITING
Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 InhibitorsNCT04526587 · 2020-07-03
RECRUITING
Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung CancerNCT03199651 · 2017-07-17
RECRUITING
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast CancerNCT00477100 · 2007-04-17
RECRUITING
Quality of Life for Patients With Breast Cancer Brain Metastases and Leptomeningeal DiseaseNCT07659652 · 2026-10-15
NOT_YET_RECRUITING
National Cancer Institute "Cancer Moonshot Biobank"NCT04314401 · 2020-11-11
ACTIVE_NOT_RECRUITING
Incidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin AmericaNCT04089488 · 2020-01-17
COMPLETED
Fluid Biopsy for the Diagnosis of Lung CancerNCT04162678 · 2020-01-13
TERMINATED
Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast CancerNCT03737695 · 2019-09-16
ACTIVE_NOT_RECRUITING
Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast CancerNCT04087057 · 2019-08-23
COMPLETED
Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast CancerNCT04022772 · 2019-07-31
COMPLETED
Genetics and Shared Decision Making in Improving Care for Patients With Stage IVA-C Non-small Cell Lung CancerNCT03944265 · 2019-02-08
COMPLETED
Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation TherapyNCT03135782 · 2017-08-01
COMPLETED
Development of a Patient Decision Aid for Women Considering Breast ReconstructionNCT04817709 · 2017-03-20
COMPLETED
Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical HyperplasiaNCT02342730 · 2014-12-17
COMPLETED
Questionnaires in Identifying Upper Extremity Function and Quality of Life After Treatment in Patients With Breast CancerNCT02370264 · 2012-10-01
TERMINATED
Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199NCT01445275 · 2011-01-01
WITHDRAWN

Common conditions

Invasive Breast Carcinoma5Anatomic Stage IV Breast Cancer AJCC v84Anatomic Stage III Breast Cancer AJCC v83Breast Carcinoma3Recurrent Breast Carcinoma3Anatomic Stage I Breast Cancer AJCC v82Anatomic Stage II Breast Cancer AJCC v82Fallopian Tube Carcinoma2HER2-Negative Breast Carcinoma2Lung Carcinoma2Lung Non-Small Cell Carcinoma2Metastatic Breast Carcinoma2Ovarian Carcinoma2Primary Peritoneal Carcinoma2Stage IV Lung Cancer AJCC v82Triple-Negative Breast Carcinoma2Activating ALK Gene Mutation Negative1Activating EGFR Gene Mutation Negative1Activating ROS1 Gene Mutation Negative1Acute Myeloid Leukemia1Brain Metastases From Breast Cancer1Breast Cancer, Metastatic1Breast Cancer, Metastatic Breast Cancer1Breast Cancer, Quality of Life1Breast Ductal Carcinoma In Situ1

Trial status mix

COMPLETED7
RECRUITING6
ACTIVE_NOT_RECRUITING2
TERMINATED2
NOT_YET_RECRUITING1
WITHDRAWN1

Phase mix

NA7
PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.